These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1477096)

  • 21. Interaction of acetylcholinesterase with the G4 domain of the laminin alpha1-chain.
    Johnson G; Swart C; Moore SW
    Biochem J; 2008 May; 411(3):507-14. PubMed ID: 18215127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-affinity no-carrier-added 99mTc-labeled chemotactic peptides for studies of inflammation in vivo.
    Baidoo KE; Scheffel U; Stathis M; Finley P; Lever SZ; Zhan Y; Wagner HN
    Bioconjug Chem; 1998; 9(2):208-17. PubMed ID: 9548536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of interaction between human skin fibroblasts and elastin: differences between elastin fibres and derived peptides.
    Groult V; Hornebeck W; Ferrari P; Tixier JM; Robert L; Jacob MP
    Cell Biochem Funct; 1991 Jul; 9(3):171-82. PubMed ID: 1721559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
    J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A subpopulation of cultured human promyelocytic leukemia cells (HL-60) displays the formyl peptide chemotactic receptor.
    Niedel J; Kahane I; Lachman L; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1980 Feb; 77(2):1000-4. PubMed ID: 6928654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on alpha v beta 3/ligand interactions using a [3H]SK&F-107260 binding assay.
    Wong A; Hwang SM; McDevitt P; McNulty D; Stadel JM; Johanson K
    Mol Pharmacol; 1996 Sep; 50(3):529-37. PubMed ID: 8794891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myelopeptides: isolation and structure].
    Fonina LA; Gur'ianov SA; Efremov MA; Smirnova OV
    Bioorg Khim; 1998 Jun; 24(6):403-7. PubMed ID: 9702349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demonstration of a chemotactic factor receptor on macrophages.
    Snyderman R; Fudman EJ
    J Immunol; 1980 Jun; 124(6):2754-7. PubMed ID: 7373048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
    Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
    Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibronectin receptor of human macrophages recognizes the sequence Arg-Gly-Asp-Ser.
    Wright SD; Meyer BC
    J Exp Med; 1985 Aug; 162(2):762-7. PubMed ID: 3160809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the rat neutrophil formyl peptide chemotaxis receptor.
    Marasco WA; Fantone JC; Freer RJ; Ward PA
    Am J Pathol; 1983 Jun; 111(3):273-81. PubMed ID: 6305198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of [3H]-SK&F 107260 and [3H]-SB 214857 to purified integrin alphaIIbbeta3: evidence for a common binding site for cyclic arginyl-glycinyl-aspartic acid peptides and nonpeptides.
    Wong A; Hwang SM; Johanson K; Samanen J; Bennett D; Landvatter SW; Chen W; Heys JR; Ali FE; Ku TW; Bondinell W; Nichols AJ; Powers DA; Stadel JM
    J Pharmacol Exp Ther; 1998 Apr; 285(1):228-35. PubMed ID: 9536015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibition of the binding and activation of the first component of human complement. The effect of synthetic peptides, immunoglobulin fragments and various proteins].
    Kozlov LV; Sizoĭ MN; Zinchenko AA; Levkovskiĭ AV
    Biokhimiia; 1986 May; 51(5):707-18. PubMed ID: 3486677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-alopecia effect of Gly-Leu-Phe, an immunostimulating peptide derived from alpha-lactalbumin.
    Tsuruki T; Yoshikawa M
    Biosci Biotechnol Biochem; 2005 Aug; 69(8):1633-5. PubMed ID: 16116300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the formyl peptide chemotactic receptor appearing at the phagocytic cell surface after exposure to phorbol myristate acetate.
    Gardner JP; Melnick DA; Malech HL
    J Immunol; 1986 Feb; 136(4):1400-5. PubMed ID: 3511145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
    Vilner BJ; John CS; Bowen WD
    Cancer Res; 1995 Jan; 55(2):408-13. PubMed ID: 7812973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
    Ruggeri ZM; Houghten RA; Russell SR; Zimmerman TS
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5708-12. PubMed ID: 3016716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of specific receptors for N-formylated chemotactic peptides in a human monocyte cell line stimulated with lymphokines.
    Pike MC; Fischer DG; Koren HS; Snyderman R
    J Exp Med; 1980 Jul; 152(1):31-40. PubMed ID: 7400755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.